The specialty pharmaceutical company, Avenue Therapeutics Inc. (ATXI) is rising in the premarket today on April 5, 2022. At the time of writing, the stock
On February 28, shares of Avenue Therapeutics Inc. (ATXI) continued to rise in the after-hours to add a humungous 73.58%. The stock had already increased
Following the announcement of a $2.0M public offering, Avenue Therapeutics Inc. (ATXI) was down by 15.9% at the last check, in the premarket today. In
Avenue Therapeutics, Inc. (ATXI), a specialty pharmaceutical company, has declined 5.29% in aftermarket trading session. Consequently, ATXI stock is trading at $1.61 at the time of
Avenue Therapeutics Inc. (ATXI) shares fell -45.84% to $2.28 in premarket trade today. Last trading session, Avenue stock has fallen -3.44% to $4.21. ATXI stock
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.